Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Lanfranco Fattorini"'
Publikováno v:
Microorganisms, Vol 11, Iss 6, p 1511 (2023)
The lungs of tuberculosis (TB) patients contain a spectrum of granulomatous lesions, ranging from solid and well-vascularized cellular granulomas to avascular caseous granulomas. In solid granulomas, current therapy kills actively replicating (AR) in
Externí odkaz:
https://doaj.org/article/d76e6bccba624832b5582ec118d16808
Autor:
Narjess Bostanghadiri, Faramarz Masjedian Jazi, Shabnam Razavi, Lanfranco Fattorini, Davood Darban-Sarokhalil
Publikováno v:
Frontiers in Microbiology, Vol 12 (2022)
BackgroundTuberculosis (TB) is still one of the most important causes of death worldwide. The lack of timely attention on TB diagnosis and treatment during the coronavirus disease 2019 (COVID-19) pandemic is a potential threat to health issues and ma
Externí odkaz:
https://doaj.org/article/8ab919298bac483abce372ea8c010acf
Autor:
Alessio Lanni, Emanuele Borroni, Angelo Iacobino, Cristina Russo, Leonarda Gentile, Lanfranco Fattorini, Federico Giannoni
Publikováno v:
Microorganisms, Vol 10, Iss 7, p 1421 (2022)
Infections caused by Mycobacterium abscessus (Mab), an environmental non-tuberculous mycobacterium, are difficult to eradicate from patients with pulmonary diseases such as cystic fibrosis and bronchiectasis even after years of antibiotic treatments.
Externí odkaz:
https://doaj.org/article/bd1ce9146a7549a8891e7d65287ba116
Autor:
Giulia Degiacomi, Laurent Roberto Chiarelli, Deborah Recchia, Elena Petricci, Beatrice Gianibbi, Ersilia Vita Fiscarelli, Lanfranco Fattorini, Fabrizio Manetti, Maria Rosalia Pasca
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 16, p 8533 (2021)
Some nontuberculous mycobacteria (NTM) are considered opportunistic pathogens. Nevertheless, NTM infections are increasing worldwide, becoming a major public health threat. Furthermore, there is no current specific drugs to treat these infections, an
Externí odkaz:
https://doaj.org/article/9d9d875b3bc349c49b022b3aeeab9d33
Autor:
Angelo Iacobino, Giovanni Piccaro, Federico Giannoni, Alessandro Mustazzolu, Lanfranco Fattorini
Publikováno v:
International Journal of Mycobacteriology, Vol 6, Iss 3, Pp 213-221 (2017)
Current tuberculosis (TB) treatment requires 6 months of combination therapy with isoniazid (INH), rifampin (RIF), pyrazinamide (PZA), and ethambutol for active TB and 9 months of INH or 3 months of rifapentine (RFP) + INH for latent TB. The lungs of
Externí odkaz:
https://doaj.org/article/fc1fbf8c7b1044e7a3a8ca906313c7c9
Publikováno v:
Microorganisms, Vol 9, Iss 2, p 255 (2021)
Previous studies on Escherichia coli demonstrated that sub-minimum inhibitory concentration (MIC) of fluoroquinolones induced the SOS response, increasing drug tolerance. We characterized the transcriptional response to moxifloxacin in Mycobacterium
Externí odkaz:
https://doaj.org/article/50192a84aca841a4be894e1b23b67146
Publikováno v:
Applied Sciences, Vol 10, Iss 6, p 2153 (2020)
The control of tuberculosis (TB) is hampered by the emergence of multidrug-resistant (MDR) Mycobacterium tuberculosis (Mtb) strains, defined as resistant to at least isoniazid and rifampin, the two bactericidal drugs essential for the treatment of th
Externí odkaz:
https://doaj.org/article/9150015be69e4253808890ac442b34a5
Autor:
Loredana Ingrosso, Fenicia Vescio, Massimo Giuliani, Giovanni Battista Migliori, Lanfranco Fattorini, Santino Severoni, Giovanni Rezza
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e94728 (2014)
In Italy, TB notifications in foreign-born people (FBP) are steadily increasing. To investigate this issue we did a meta-analysis on risk factors for FBP people. A systematic search was performed in PubMed and EMBASE from Jan-1980 to Jan-2013. We ana
Externí odkaz:
https://doaj.org/article/68173a0f0eeb4e03946d1fea74616302
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 5, Iss 1, Pp e2013072-e2013072 (2013)
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (Mtb), which kills about 2 million people annually. Furthermore, 2 billion people worldwide are latently infected with this organism, with 10% of them reactivating to act
Externí odkaz:
https://doaj.org/article/f28e294cb341487ba163bb4721800f6b
Autor:
Manuela Pardini, Elisabetta Iona, Francis Varaine, Hayk Karakozian, Herchanik Arzumanian, Lara Brunori, Graziella Orefici, Lanfranco Fattorini
Publikováno v:
Emerging Infectious Diseases, Vol 11, Iss 3, Pp 501-503 (2005)
Externí odkaz:
https://doaj.org/article/cd0e861a0da24828afe2b9d4f6cc3a2b